Description:This application describes an alpha-gal based vaccine to prevent and treat infectious diseases, especially Chagas disease cause by T. cruzi.
Abstract:Certain embodiments are directed to method for synthesizing and using glycoconjugates on the immunodominant epitope Galα(1,3)Galβ(1,4)GlcNAcα (Galα3LNα).
Issue Date: 02/16/2021
Application Date: 07/26/2019
Post Date: 07/26/2019
UTEP Docket No: 2015-011
